Publications

Link to publications on PubMed here.

Link to Google Scholar profile here.

 

Original articles

1. Panda, S.K., S.V. Boddul, G.Y. Jiménez-Andrade, L. Jiang, Z. Kasza, L. Fernandez-Ricaud, and Wermeling F.

Green Listed – A CRISPR Screen Tool.

Bioinformatics. 2016 Dec 22, doi: 10.1093/bioinformatics/btw739. link

 

2. Duhlin A, Chen Y, Wermeling F, Sedimbi SK, Lindh E, Shinde R, Halaby MJ, Kaiser Y, Winqvist O, McGaha TL, Karlsson MC.

Selective Memory to Apoptotic Cell-Derived Self-Antigens with Implications for Systemic Lupus Erythematosus Development.

J Immunol. 2016 Aug 24. pii: 1401129. [Epub ahead of print]. link

 

3. Prokopec KE, Georgoudaki AM, Sohn S, Wermeling F, Grönlund H, Lindh E, Carroll MC, Karlsson MC.

Cutting Edge: Marginal Zone Macrophages Regulate Antigen Transport by B Cells to the Follicle in the Spleen via CD21.

J Immunol. 2016 Aug 15. pii: 1502282. [Epub ahead of print]. link

 

4. Kritikou JS, Dahlberg C, Baptista MA, Wagner AK, Banerjee PP, Gwalani LA, Poli C, Panda SK, Kärre K, Kaech SM, Wermeling F, Andersson J, Orange JS, Brauner H, Westerberg LS

IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo

Scientific Reports 2016 In press. link

 

5. Bosma M, Gerling M, Pasto J, Georgiadi A, Graham E, Shilkova O, Iwata Y, Almer S, Söderman J, Toftgård R, Wermeling F, Boström EA, Boström PA.

FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice.

Nat Commun. 2016 Apr 12;7:11314. doi: 10.1038/ncomms11314. link

 

6. Siegmann N, Worbs D, Effinger F, Bormann T, Gebhardt M, Ulrich M, Wermeling F, Müller-Hermelink E, Biedermann T, Tighe M, Edwards MJ, Caldwell C, Leadbetter E, Karlsson MC, Becker KA, Gulbins E, Döring G.

Invariant natural killer T (iNKT) cells prevent autoimmunity, but induce pulmonary inflammation in cystic fibrosis.

Cell Physiol Biochem. 2014;34(1):56-70. doi: 10.1159/000362984. Epub 2014 Jun 16. link

 

7. Wermeling F, Anthony RM, Brombacher F, and Ravetch JV.

Acute inflammation primes myeloid effector cells for anti-inflammatory STAT6 signaling.

Proc Natl Acad Sci U S A. 2013 Jul 29.  link, PDF

 

8. Lindh E, Brännström J, Jones P, Wermeling F, Hässler S, Betterle C, Garty BZ, Stridsberg M, Herrmann B, Karlsson MCI, and Winqvist O.

Autoimmunity and cystatin SA 1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome type 1.

J Autoimmun. 2012 Oct link

 

9. Anthony RM, Kobayashi T, Wermeling Fand Ravetch JV.

Intravenous gammaglobulin suppresses inflammation through a Novel TH2 Pathway. 

Nature. 2011 Jun:475(7354):110-3 link

 

10.Sakthivel P, Wermeling F, Elmgren A, Hulthe J, Kakoulidou M, Lefvert AK and Lind L.

Circulating soluble CTLA-4 is related to inflammatory markers in the 70 year old population.

Scand J Clin Lab Invest. 2010 Jul:70(4):237-43 link

 

11. Wermeling F, Lind S. M, Domange Jordö E., Cardell S, and Karlsson MCI.

Invariant NKT cells limit activation of autoreactive CD1d positive B cells.

J  Exp Med. 2010 May 10;207(5):943-52 linkPDF

[Highlighted in Nat Rev Immunol. 2010 Jun;10(6):384 link]

 

12. Chen Y, Wermeling F, Sundqvist J, Jonsson AB, Tryggvason K, Pikkarainen T and Karlsson MCI.

A regulatory role for macrophage class A scavenger receptors in TLR4-mediated LPS responses.

Eur J Immunol. 2010 May;40(5):1451-60 link

 

13. Thunberg S, Neimert-Andersson T, Cheng Q, Wermeling F, Bergström U, Swedin L, Dahlén SE, Arnér E, Scheynius A, Karlsson MCI, Gafvelin G, van Hage M, Grönlund H.

Prolonged antigen-exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice.

Allergy. 2009 Jun;64(6):919-26 link

 

14. Anthony RM, Wermeling F, Karlsson MCI and Ravetch JV.

Identification of a receptor required for the anti-inflammatory activity of IVIG.

Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19571-8 link

 

15. Westerberg L, A. de la Fuente M, Wermeling F, Ochs HD, Karlsson MCI, Snapper SB and Notarangelo LD.

WASP Confers Selective Advantage for Specific Hematopoietic Cell Populations and Serves a Unique Role in Marginal Zone B cell Development and Function.

Blood. 2008 Nov 15;112(10):4139-47 link

 

16. Wermeling F, Chen Y, Pikkarainen T, Scheynius A, Winqvist O, Izui S, Ravetch JV, Tryggvason K, and Karlsson MC.

Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus.

J Exp Med. 2007 Oct 1;204(10):2259-65 linkPDF

[Highlighted in Nat Clin Pract Rheumatology, 2008, 4:7]

——-

Reviews:

1. Anthony RM, Wermeling Fand Ravetch JV.

Novel roles of the IgG Fc glycan. 

Ann N Y Acad Sci. 2012 Jan 30 link

 

2. Jordö ED, Wermeling F, Chen Y and Karlsson MCI.

Scavenger receptors as regulators of natural antibody responses and B cell activation in autoimmunity.

Mol Immunol. 2011 Jun:48(11):1307-18 link

 

3. Wermeling F, Karlsson MCI, McGaha TL.

An anatomical view on macrophages in tolerance.

Autoimmun Rev. 2009 Sep;9(1):49-52. Epub 2009 Mar 10 link

 

——-

Thesis:

Innate Mechanisms Regulating Peripheral B cell Tolerance, 2010, PDF